MING XU
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- Bourbonnais, IL
- NPI
- 1548271018
- Received
- $505,223 in 842 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 138 | $116,917 |
| 2024 | General payment | 153 | $97,995 |
| 2023 | General payment | 147 | $103,528 |
| 2022 | General payment | 152 | $76,604 |
| 2021 | General payment | 103 | $51,836 |
| 2020 | General payment | 81 | $44,803 |
| 2019 | General payment | 68 | $13,536 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 253 | $184,275 | 2021–2025 |
| Allergan, Inc. | 119 | $59,327 | 2019–2021 |
| Axsome Therapeutics, Inc. | 61 | $55,241 | 2022–2025 |
| Supernus Pharmaceuticals, Inc. | 83 | $48,616 | 2022–2025 |
| Alkermes, Inc. | 50 | $34,529 | 2022–2025 |
| E.R. Squibb & Sons, L.L.C. | 46 | $32,243 | 2024–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 41 | $31,587 | 2020–2024 |
| Vanda Pharmaceuticals Inc. | 45 | $24,124 | 2022–2025 |
| Teva Pharmaceuticals USA, Inc. | 28 | $17,631 | 2022–2025 |
| Corium, LLC | 15 | $8,621 | 2023–2024 |
| IDORSIA PHARMACEUTICALS US INC | 7 | $7,466 | 2023 |
| Sunovion Pharmaceuticals Inc. | 38 | $322 | 2019–2021 |
| Otsuka America Pharmaceutical, Inc. | 10 | $299 | 2019–2023 |
| Janssen Pharmaceuticals, Inc | 11 | $192 | 2020–2023 |
| Biogen, Inc. | 8 | $179 | 2020–2021 |
| MicroVention, Inc. | 1 | $117 | 2021 |
| Eisai Inc. | 7 | $104 | 2020–2021 |
| Lundbeck LLC | 6 | $94 | 2022–2023 |
| Merck Sharp & Dohme LLC | 3 | $52 | 2021–2023 |
| Boston Scientific Corporation | 1 | $51 | 2023 |
| Almatica Pharma LLC | 3 | $40 | 2021–2022 |
| Bausch Health US, LLC | 2 | $38 | 2022 |
| Indivior Inc. | 1 | $21 | 2022 |
| Neurocrine BioSciences, Inc. | 1 | $16 | 2022 |
| IRONSHORE PHARMACEUTICALS INC. | 1 | $15 | 2022 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 231 | $404,398 |
| Consulting Fee | 16 | $40,155 |
| Honoraria | 7 | $24,200 |
| Travel and Lodging | 143 | $21,576 |
| Food and Beverage | 444 | $14,853 |
| Education | 1 | $39 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | E.R. Squibb & Sons, L.L.C. | $119 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-17 | E.R. Squibb & Sons, L.L.C. | $86 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-30 | Teva Pharmaceuticals USA, Inc. | $420 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-11-26 | E.R. Squibb & Sons, L.L.C. | $4,140 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-14 | E.R. Squibb & Sons, L.L.C. | $1,037 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-14 | E.R. Squibb & Sons, L.L.C. | $463 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-04 | E.R. Squibb & Sons, L.L.C. | $193 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-03 | Teva Pharmaceuticals USA, Inc. | $3,094 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-10-31 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-29 | Alkermes, Inc. | $2,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-10-16 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-15 | Alkermes, Inc. | $124 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-10-14 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $560 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $51 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-02 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-02 | E.R. Squibb & Sons, L.L.C. | $122 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-30 | ABBVIE INC. | $92 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | E.R. Squibb & Sons, L.L.C. | $184 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $113 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $30 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-02 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-25 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $79 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $69 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $49 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $32 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $29 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $3 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-16 | Vanda Pharmaceuticals Inc. | $2 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $4,455 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $649 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $389 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $325 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $219 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $178 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-15 | Vanda Pharmaceuticals Inc. | $86 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-08-14 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-14 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | Alkermes, Inc. | $800 | Consulting Fee | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-08-12 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-06 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | ABBVIE INC. | $16 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-30 | E.R. Squibb & Sons, L.L.C. | $36 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-25 | Axsome Therapeutics, Inc. | $2,750 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-25 | Axsome Therapeutics, Inc. | $78 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-25 | Axsome Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-23 | ABBVIE INC. | $29 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-23 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-03 | Supernus Pharmaceuticals, Inc. | $39 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-02 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-27 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $2,750 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $89 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-24 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-18 | Axsome Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-17 | Axsome Therapeutics, Inc. | $2,750 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-17 | Axsome Therapeutics, Inc. | $93 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-11 | ABBVIE INC. | $88 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-11 | ABBVIE INC. | $25 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-03 | Axsome Therapeutics, Inc. | $3,575 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-03 | Axsome Therapeutics, Inc. | $125 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-03 | Axsome Therapeutics, Inc. | $92 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-28 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-28 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-23 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-05-20 | Teva Pharmaceuticals USA, Inc. | $3,094 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-05-20 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-20 | Teva Pharmaceuticals USA, Inc. | $91 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-05-14 | ABBVIE INC. | $109 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-08 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-07 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-05-06 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-02 | ABBVIE INC. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-01 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-30 | E.R. Squibb & Sons, L.L.C. | $26 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-25 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-24 | Alkermes, Inc. | $3,830 | Consulting Fee | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-04-23 | Alkermes, Inc. | $2,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-04-23 | Teva Pharmaceuticals USA, Inc. | $1,470 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-04-22 | ABBVIE INC. | $91 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-22 | E.R. Squibb & Sons, L.L.C. | $35 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-22 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-18 | E.R. Squibb & Sons, L.L.C. | $197 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-17 | Vanda Pharmaceuticals Inc. | $2,145 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-17 | Vanda Pharmaceuticals Inc. | $638 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-17 | Vanda Pharmaceuticals Inc. | $156 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-17 | Vanda Pharmaceuticals Inc. | $30 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-15 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-11 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-10 | Alkermes, Inc. | $91 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-08 | E.R. Squibb & Sons, L.L.C. | $79 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-05 | Alkermes, Inc. | $75 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-05 | Alkermes, Inc. | $60 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-05 | Alkermes, Inc. | $48 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-05 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-05 | Alkermes, Inc. | $2 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-04 | Alkermes, Inc. | $25 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-04 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-04-03 | Axsome Therapeutics, Inc. | $7,150 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-02 | Alkermes, Inc. | $2,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-04-02 | Vanda Pharmaceuticals Inc. | $1,980 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-02 | Vanda Pharmaceuticals Inc. | $115 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-04-01 | E.R. Squibb & Sons, L.L.C. | $120 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-27 | Alkermes, Inc. | $1,910 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-03-27 | Alkermes, Inc. | $200 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-03-25 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-25 | Alkermes, Inc. | $64 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-03-19 | Alkermes, Inc. | $3,190 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-03-18 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $422 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $258 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $78 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $48 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $45 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $32 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $29 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-15 | Axsome Therapeutics, Inc. | $26 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-03-11 | Alkermes, Inc. | $63 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-03-10 | ABBVIE INC. | $82 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-10 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | E.R. Squibb & Sons, L.L.C. | $690 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-06 | Supernus Pharmaceuticals, Inc. | $34 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-02-25 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-02-21 | E.R. Squibb & Sons, L.L.C. | $91 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-20 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-19 | E.R. Squibb & Sons, L.L.C. | $161 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-14 | Supernus Pharmaceuticals, Inc. | $62 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-02-04 | E.R. Squibb & Sons, L.L.C. | $135 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-09 | Vanda Pharmaceuticals Inc. | $4 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-01-06 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2024-12-09 | Axsome Therapeutics, Inc. | $2,500 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-12-09 | Axsome Therapeutics, Inc. | $81 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-12-09 | Axsome Therapeutics, Inc. | $33 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-11-20 | Vanda Pharmaceuticals Inc. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-11-20 | Vanda Pharmaceuticals Inc. | $191 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-11-20 | Vanda Pharmaceuticals Inc. | $49 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-10-11 | Vanda Pharmaceuticals Inc. | $2 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $58 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-04 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-09-30 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-27 | Vanda Pharmaceuticals Inc. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-09-27 | Vanda Pharmaceuticals Inc. | $188 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-09-27 | Vanda Pharmaceuticals Inc. | $102 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-09-23 | Teva Pharmaceuticals USA, Inc. | $2,730 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2024 | |
| 2024-09-23 | Teva Pharmaceuticals USA, Inc. | $88 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-09-23 | Teva Pharmaceuticals USA, Inc. | $80 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2024 | |
| 2024-09-18 | Axsome Therapeutics, Inc. | $113 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-09-10 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-10 | ABBVIE INC. | $2,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-04 | E.R. Squibb & Sons, L.L.C. | $135 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-08-28 | Axsome Therapeutics, Inc. | $2,250 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-08-28 | Axsome Therapeutics, Inc. | $117 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-08-27 | Vanda Pharmaceuticals Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-08-27 | Vanda Pharmaceuticals Inc. | $100 | Food and Beverage | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-08-27 | Vanda Pharmaceuticals Inc. | $41 | Travel and Lodging | Cash or cash equivalent | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-08-26 | ABBVIE INC. | $79 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-26 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-21 | ABBVIE INC. | $44 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-21 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-20 | Vanda Pharmaceuticals Inc. | $13 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-08-16 | Corium, LLC | $22 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-08-13 | Supernus Pharmaceuticals, Inc. | $25 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-08-09 | Vanda Pharmaceuticals Inc. | $8 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-08-07 | Supernus Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-08-06 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-01 | Supernus Pharmaceuticals, Inc. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-08-01 | Supernus Pharmaceuticals, Inc. | $17 | Travel and Lodging | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-07-31 | Supernus Pharmaceuticals, Inc. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-07-31 | Supernus Pharmaceuticals, Inc. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-07-31 | Supernus Pharmaceuticals, Inc. | $14 | Travel and Lodging | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-07-31 | Supernus Pharmaceuticals, Inc. | $10 | Travel and Lodging | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2024 | |
| 2024-07-25 | Vanda Pharmaceuticals Inc. | $7 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-07-23 | Alkermes, Inc. | $1,910 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2024 | |
| 2024-07-22 | Axsome Therapeutics, Inc. | $2,500 | Consulting Fee | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-07-22 | Axsome Therapeutics, Inc. | $83 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-07-19 | Vanda Pharmaceuticals Inc. | $6 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-07-17 | Corium, LLC | $3,780 | Consulting Fee | Cash or cash equivalent | AZSTARYS Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-07-17 | Corium, LLC | $160 | Consulting Fee | Cash or cash equivalent | AZSTARYS Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-07-16 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-12 | Vanda Pharmaceuticals Inc. | $6 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2024 | |
| 2024-07-10 | Alkermes, Inc. | $5,430 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2024 | |
| 2024-07-10 | Alkermes, Inc. | $85 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-07-10 | Alkermes, Inc. | $56 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-07-10 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-07-10 | Alkermes, Inc. | $21 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-07-10 | Alkermes, Inc. | $17 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2024 | |
| 2024-06-28 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 |
The latest 200 records of 842.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Bourbonnais, IL, county Kankakee County, IL, state Illinois; placed by its city name.
| Measure | Place (city or town) Bourbonnais, IL | County Kankakee County, IL | State Illinois |
|---|---|---|---|
| Population B01003 | 18,078 | 106,635 | 12,694,798 |
| Population, 2020 census P1 | 18,164 | 107,502 | 12,812,508 |
| Median age B01002 | 35.8 | 39.0 | 39.0 |
| Under 18 B01001 | 20.6% | 22.8% | 21.8% |
| 65 and over B01001 | 15.2% | 17.8% | 17.0% |
| Households B11001 | 6,179 | 40,996 | 5,036,449 |
| Foreign born B05002 | 4.5% | 5.7% | 14.7% |
| Median household income B19013 | $81,708 | $71,281 | $83,390 |
| Median family income B19113 | $102,519 | $88,854 | $106,018 |
| Per capita income B19301 | $36,367 | $36,825 | $46,406 |
| Poverty rate B17001 | 9.5% | 12.2% | 11.8% |
| Unemployment rate B23025 | 6.1% | 4.9% | 5.8% |
| Civilian labor force B23025 | 9,479 | 52,754 | 6,652,134 |
| Mean commute (minutes) B08013 | 19.6 | 24.9 | 27.8 |
| Bachelor's degree or higher B15003 | 34.1% | 21.2% | 37.8% |
| Housing units B25001 | 6,711 | 45,415 | 5,457,452 |
| Owner-occupied B25003 | 73.4% | 69.9% | 67.1% |
| Renters B25003 | 26.6% | 30.1% | 32.9% |
| Median home value B25077 | $253,100 | $192,600 | $263,300 |
| Median gross rent B25064 | $1,269 | $1,097 | $1,274 |
| White, not Hispanic B03002 | 73.5% | 68.0% | 58.1% |
| Black B03002 | 9.3% | 14.3% | 13.3% |
| Hispanic or Latino B03002 | 7.5% | 12.7% | 18.8% |
| Asian B03002 | 3.7% | 1.0% | 5.9% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 4.6% in Sep 2026 (4.5% a year earlier); per capita personal income $78,987 in 2025, up 28% in five years (+3.1% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bourbonnais, IL.
Comments